Prevention of cancer therapy‐related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio‐Oncology

Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. CTR-CVT, cancer therapy-related cardiovascular toxicity; CVD, cardiovascular disease; CVRF…

Read the full article here

Related Articles

Prevention of cancer therapy‐related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio‐Oncology

Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. CTR-CVT, cancer therapy-related cardiovascular toxicity; CVD, cardiovascular disease; CVRF…